Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay Bradner

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Science Advances|August 25, 2020
Inhibition of Polo-like kinase 1 (PLK1) facilitates the elimination of HIV-1 viral reservoirs in CD4<sup>+</sup> T cells ex vivoDawei Zhou, Tsuyoshi Hayashi, Maxime Jean, et al.
Nature Biotechnology|June 10, 2016
Erratum: Community crystal gazingAnu Acharya, Kate Bingham, Jay Bradner, et al.
Nature Biotechnology|March 11, 2016
Community crystal gazingAnu Acharya, Kate Bingham, Jay Bradner, et al.
The Journal of Infectious Diseases|June 10, 2021
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics SummitMatthew D Hall, James M Anderson, Annaliesa Anderson, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Science Advances|August 25, 2020
Inhibition of Polo-like kinase 1 (PLK1) facilitates the elimination of HIV-1 viral reservoirs in CD4<sup>+</sup> T cells ex vivoDawei Zhou, Tsuyoshi Hayashi, Maxime Jean, et al.
Nature Biotechnology|June 10, 2016
Erratum: Community crystal gazingAnu Acharya, Kate Bingham, Jay Bradner, et al.
Nature Biotechnology|March 11, 2016
Community crystal gazingAnu Acharya, Kate Bingham, Jay Bradner, et al.
The Journal of Infectious Diseases|June 10, 2021
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics SummitMatthew D Hall, James M Anderson, Annaliesa Anderson, et al.
Pageof 1